Clinical Trial Update: Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial [Phase 2]

View source ↗

Summary

Phase II clinical trial of lenalidomide for advanced hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Brown University | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-03